Skip to Content

Modern Pharma Company

Diclof S.R 100

Diclof S.R 100

Finished Goods / Analgesics, Antipyretics, Anti-Inflammatory drugs
- Diclofenac sodium, a phenylacetic acid derivative, is a non-steroidal compound with pronounced antirheumatic, anti-inflammatory, analgesic and antipyretic properties.
- It inhibits prostaglandin biosynthesis which plays a major role in causing inflammation, pain and fever. Medication with Diclofenac sodium can relieve the symptoms of inflammation, but can not cure the cause. In rheumatic diseases, Diclofenac sodium elicits a clinical response characterized by marked relief from signs and symptoms such as pain at rest, pain on movement, morning stiffness, and swelling of the joints, as well as by an improvement in function.
- Diclofenac is almost completely absorbed. Food has no clinical relevant influence on the absorption and bioavailability of Diclofenac.
- No accumulation occurs provided the recommended dosage intervals are observed even in patients suffering from renal impairment. 99.7% of Diclofenac is bound to serum proteins. It enters the synovial fluid, and reaches higher levels in the synovial fluid than in the plasma and remain higher for up to 12 hours.
- Diclofenac is subject to first-pass metabolism and then excreted mainly in the urine (about 65%) but also in the bile (about 35%).

Indication

DICLOF ® is used in: 
- Inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis. 
- Painful syndromes of the vertebral column. 
- Non-articular rheumatism. 
- Post-traumatic and postoperative pain, inflammation, and swelling. 
- Painful and inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis.    
- Soft tissue injuries: sprain and strain. 
- Acute infectious diseases, especially of the ear, nose and throat. 
- Dental pain, renal and biliary colics.
-  Acute gout and Juvenile rheumatoid arthritis. 

Dosage & Administration

- The dose should be adjusted to the patient’s response, tolerance and severity of symptoms. 

- DICLOF ® capsules or tablets should be swallowed whole with plenty of  liquid preferably during or  after meals. 

Adults: 

The recommended daily dosage is 75 -150 mg as the following: 

- One capsule of DICLOF ® SR 100 per day during long term treatment. 

- Or 1 -3 enteric coated tablets of 25 mg or 50 mg/day in 2- 3 divided doses

- In primary dysmenorrhoea the daily dosage should be individually adjusted and generally 50-150 mg. 

Children: 

- The initial dose for children  aged 6 years and over: 2-3 mg per Kg body weight / day, in 2 - 3 divided doses.

- The dose range is between 0.5-2 mg/Kg body weight daily, according to the severity of the case.

- In case of juvenile rheumatoid arthritis, the dose can be increased to 3 mg/Kg  body weight daily on 2-3 divided doses.

- DICLOF ®should not be given to children under 12 months of age.

- Or as directed by physician

- Each Capsule of DICLOF ® S.R 100 contains: 
   Diclofenac sodium     100 mg  
- Each Enteric Coated Tablet  of  DICLOF ®  50 contains: 
   Diclofenac sodium     50 mg  
- Each Enteric Coated Tablet of  DICLOF ®   25 contains:
   Diclofenac sodium     25 mg
 - Each Suppository  of  DICLOF®   25 contains:
   Diclofenac sodium     25 mg
- Each Suppository  of  DICLOF ®   12.5 contains::
   Diclofenac sodium     12.5 mg

- Hypersensitivity to Diclofenac. 
- DICLOF ® should not be given to patients with peptic ulcer and to patients who have experienced asthma, urticaria, or other allergic-type reactions caused by Aspirin or other  NSAIDs. 

- Like other NSAIDs, DICLOF ® may reduce the efficacy of diuretics. 
- Concomitant treatment with a potassium-sparing diuretic may be associated with increased serum potassium levels, which should therefore be monitored frequently. 
- Patients taking DICLOF ® and are also receiving Digoxin, Methotrexate, Cyclosporin or Lithium should be observed for potential development of the specific toxicities of these drugs. 
- Concomitant administration of other systemic NSAIDs or Glucocorticoids may increase the occurrence of side effects. 
- Cholestyramine appears to reduce the bioavailability of Diclofenac when the two drugs are given together; Colestipol produces a similar action but smaller effect. 

- Owing to the possibility of uterine inertia and/or premature closure of the ductus arteriosus, DICLOF ® should not be used in the third trimester. 

- DICLOF ® passes into breast milk, but in quantities so small to be harmful to a breast-fed infant

- DICLOF ® is generally well tolerated. The most common side effects include gastro-intestinal disturbances, headache, dizziness, Fluid retention, liver function disorders, rash and pruritis have been reported. 

* As with other NSAIDs, DICLOF ® should be used with caution:
- In patients with impaired hepatic or renal function.
- History of cardiovascular diseases and  peptic ulcer

- DICLOF ® S.R 100 mg Capsules:
   (Blisters of 10 Capsules, Pack of one blister.)
- DICLOF ® Enteric Coated Tablets 25 mg and 50 mg: 
   (Blisters of 10 enteric coated tablets, Packs of two  blisters.)
- Hospital packs of different sizes. 
- DICLOF ® Suppository  25 mg and 12.5 mg: 
   (Blisters of 5 Suppository  , Packs of one blisters.

- Store in a dry place  at a temperature below  25oC.
- Protect from moisture and light.